首页> 美国卫生研究院文献>Saudi Journal of Ophthalmology >Retinoblastoma survival disparity: The expanding horizon in developing countries
【2h】

Retinoblastoma survival disparity: The expanding horizon in developing countries

机译:视网膜母细胞瘤生存差异:发展中国家的发展前景

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The patients’ survival for the most common intraocular tumor in children, retinoblastoma, has a wide spectrum among the world countries. This study was conducted to provide an overview of the retinoblastoma survival disparity worldwide by discussing the trends of patients’ survival, as well as recent advances in the management of retinoblastoma.The design of this study was literature review and commentary. Selected articles from PubMed (except one) including both developing and developed countries regarding the patients’ survival in retinoblastoma were considered and reviewed critically. An analysis of 47 articles was performed. In conclusion, in spite of an obvious contrast of retinoblastoma survival disparity in the world, the expanding horizons in developing countries are promising and continuing on all fronts and results are hope-inspiring.
机译:在儿童中,最常见的儿童眼内肿瘤视网膜母细胞瘤患者的存活率在世界各国中广泛存在。这项研究的目的是通过讨论患者存活的趋势以及视网膜母细胞瘤管理的最新进展来概述全世界的视网膜母细胞瘤生存差异。该研究的设计是文献综述和评论。考虑并严格审查了包括和来自发展中国家和发达国家的PubMed(除一本)的部分有关成视网膜细胞瘤患者生存的文章。对47篇文章进行了分析。总之,尽管全世界视网膜母细胞瘤生存差异存在明显差异,但发展中国家不断扩大的前景是有希望的,并在各个方面都在继续,结果令人鼓舞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号